Liberty Media Sees Subscription Privileges Exercised and 4 Stocks Rising to 52-Week Highs
Liberty Media Corp. (NASDAQ:LINTA): The subscription agent has informed Liberty Media Corp., that basic subscription privileges were properly exercised for 8,918,721 shares of Series A Liberty Ventures common stock. Following the allocation of shares to rights holders exercising their basic subscription privilege, 202,652 shares of LVNTA were available for allocation among those who properly exercised their oversubscription privilege. The proration factor used for these oversubscription allocations is estimated to be approximately 3.5%. Liberty expects that beginning on or about Tuesday, October 16, the subscription agent will distribute the purchased shares in the rights offering, the refund checks for unfulfilled oversubscriptions, and the checks for the sale of proceeds of rights sold by the subscription. Their shares closed at $20.27, up $0.53 or 2.68% on the day. They have traded in a 52-week range of $14.54 to $19.80.
Lloyds Banking Group (NYSE:LYG): The Wall Street Journal reported that Spain is considering a request for a line of credit from the European Union’s new bailout mechanism. According to a senior Spanish Finance Ministry official, the country is seeking help to avoid debt problems that are spinning out of control. Their shares closed at $2.73, up $0.14 or 5.41% on the day. They have traded in a 52-week range of $1.33 to $2.62.
Catalysts are critical to discovering winning stocks. Check out our newest CHEAT SHEET stock picks now.
Mattel (NASDAQ:MAT): Mattel reported that Fisher-Price Brands are up 6% to $790.4 million, and American Girl Brands are up 16% to $102 million for the third quarter. Their shares closed at $37.20, up $1.78 or 5.03% on the day. They have traded in a 52-week range of $26.50 to $36.25.
Merck & Company (NYSE:MRK): Theravance (NASDAQ:THRX) announced that they have signed a collaboration agreement with Merck & Company, known as MSD outside the United States and Canada, to discover, develop and commercialize novel, small molecule therapeutics that are directed towards a target being investigated for the treatment of hypertension and heart failure. In exchange for granting Merck a worldwide, exclusive license to their therapeutic candidates, Theravance will receive a $5 million payment upfront, funding for research, and be eligible for milestone payments totaling up to $148 million for the first indication and royalties on worldwide net sales of any products derived from the collaboration. Their shares closed at $47.17, up $0.58 or 1.24% on the day. They have traded in a 52-week range of $32.19 to $46.63.
New York Times Company (NYSE:NYT): According to Business Insider, New York Times Company’s future Chief Executive Officer, Mark Thompson may have covered up impropriety while he was the Director General of the BBC. Thompson has denied any knowledge or involvement regarding the dozens of allegations of sexual abuse conducted by TV host Jimmy Savile. Their shares closed at $10.71, down $0.17 or 1.56% on the day. They have traded in a 52-week range of $5.88 to $10.92.
Don’t Miss: 3 Earnings Releases You Must Know Now.